Medical Equipment

Pulmonary Drug Delivery Devices Market Insights: Revenue Expected to Surpass $68.18 Billion by 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pulmonary drug delivery devices market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Pulmonary Drug Delivery Devices Market?

The market size for pulmonary drug delivery devices has experienced substantial growth in recent years. It is projected to expand from $49.52 billion in 2024 to $52.8 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. The historic period’s growth can be attributed to the increasing prevalence of respiratory diseases like chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, along with the rising global aging population. Other contributing factors include growing awareness about respiratory health’s importance, expanded healthcare expenditure in emerging economies, and the increasing adoption of homecare settings for respiratory therapy.

The pulmonary drug delivery devices market is projected to experience robust expansion in the coming years, with its size anticipated to reach $68.18 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.6%. This expected increase can be primarily attributed to the escalating demand for personalized and precision medicine within respiratory care, the widening scope of home healthcare services and remote patient monitoring, a surge in research and development investments, and a heightened focus on preventive healthcare alongside early intervention strategies. Significant trends identified for this forecast period include ongoing technological innovations, a transition towards value-based care models and patient-centric methods, the integration of telehealth and remote monitoring features into respiratory therapy platforms, the application of wearables and mobile applications for self-management of respiratory ailments, and the adoption of 3D printing and digital manufacturing techniques.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15907&type=smp

Which Growth Drivers Are Propelling The Pulmonary Drug Delivery Devices Market?

The expanding occurrence of respiratory illnesses is projected to fuel the growth of the pulmonary drug delivery devices market moving forward. These disorders encompass various diseases and conditions that impact the lungs and airways, thereby affecting an individual’s respiration. A rise in the prevalence of respiratory disorders is attributed to multiple factors, including heightened air pollution levels, a greater incidence of smoking, increasing urbanization, climate change, and an aging global population. Pulmonary drug delivery devices are vital in managing respiratory conditions as they facilitate the direct administration of medications into the lungs. For example, in May 2024, the Centers for Disease Control And Prevention (CDC), a US-based national public health agency, indicated that the prevalence of current asthma among adults aged 18 and over increased from 8.0 % in 2021 to 8.7% in 2022. Consequently, the rising incidence of respiratory disorders is anticipated to stimulate the expansion of the pulmonary drug delivery devices market.

Which Segmentation Factors Are Most Significant In The Pulmonary Drug Delivery Devices Market Analysis?

The pulmonary drug delivery devicesmarket covered in this report is segmented –

1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers

2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce

Subsegments:

1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs

2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs

3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers

Which Notable Trends Are Transforming The Pulmonary Drug Delivery Devices Market Outlook?

Leading companies in the pulmonary drug delivery devices market are developing advanced products, such as small-volume nebulizers, to provide enhanced features for customers. A small-volume nebulizer (SVN) is a medical device that administers liquid medication as an aerosolized mist to patients with respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. For example, in May 2024, Medline Industries LP, a US-based healthcare company, introduced the Hudson RCI TurboMist small-volume nebulizer. This groundbreaking device is designed to deliver medication treatments quickly, in as little as three minutes. The innovative nebulizer can dispense 2.5 times more medication per minute compared to standard nebulizers, thereby reducing treatment times by approximately 70%. This increase in medication delivery substantially shortens treatment durations, benefiting healthcare providers by optimizing patient throughput and improving the patient experience by shortening therapy sessions.

Who Are The Most Influential Companies In The Pulmonary Drug Delivery Devices Market?

Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report

Which Region Holds The Largest Share In The Pulmonary Drug Delivery Devices Market Today?

North America was the largest region in the pulmonary drug delivery devices market in 2024. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15907&type=smp

Browse Through More Reports Similar to the Global Pulmonary Drug Delivery Devices Market 2025, By The Business Research Company

Pulmonary Embolism Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

Pulmonary Arterial Hypertension Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pulmonary-arterial-hypertension-global-market-report

Chronic Obstructive Pulmonary Disease Copd Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chronic-obstructive-pulmonary-disease-copd-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795